🧬

Colon Cancer

Our colorectal cancer program investigates the rising incidence of young-onset disease in India and develops precision medicine strategies for advanced-stage patients.

Learn More
1,400+
Patients treated annually
620
Young-onset cases studied
98%
MSI testing rate

Research Themes

1

Young-Onset Colorectal Cancer

Epidemiological and molecular studies investigating why colorectal cancer rates are rising among Indian adults under 50.

2

MSI-High Immunotherapy

Checkpoint inhibitor monotherapy and combinations for microsatellite instability–high colorectal cancers.

3

ctDNA-Guided Adjuvant Therapy

Using circulating tumour DNA to identify stage II/III patients who can safely omit adjuvant chemotherapy.

4

Population Screening Strategies

Evaluating faecal immunochemical testing and colonoscopy as cost-effective screening approaches in the Indian context.

Clinical Trials

NCT06234514

Recruiting

ctDNA-Directed Adjuvant Therapy in Stage II Colon Cancer

PI: Dr. T. Rajkumar

NCT06234515

Active

Dostarlimab Monotherapy in dMMR Locally Advanced Rectal Cancer

PI: Dr. Mayilvahanan Bose

Fight Colon Cancer with Research

Your generosity supports research into why colorectal cancer is striking younger Indians and funds clinical trials of less invasive treatment approaches.

Donate Now